- Home
- PVLA vs CCIR Comparison
PVLA vs CCIR Comparison
Compare PVLA & CCIR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PVLA
- CCIR
- Stock Information
- Founded
- PVLA 2015
- CCIR 2021
- Country
- PVLA United States
- CCIR United States
- Employees
- PVLA N/A
- CCIR N/A
- Industry
- PVLA Biotechnology: Pharmaceutical Preparations
- CCIR
- Sector
- PVLA Health Care
- CCIR
- Exchange
- PVLA Nasdaq
- CCIR NYSE
- Market Cap
- PVLA 285.2M
- CCIR 340.2M
- IPO Year
- PVLA N/A
- CCIR 2024
- Fundamental
- Price
- PVLA $36.55
- CCIR $10.42
- Analyst Decision
- PVLA Strong Buy
- CCIR
- Analyst Count
- PVLA 8
- CCIR 0
- Target Price
- PVLA $47.50
- CCIR N/A
- AVG Volume (30 Days)
- PVLA 176.0K
- CCIR 629.4K
- Earning Date
- PVLA 08-15-2025
- CCIR 01-01-0001
- Dividend Yield
- PVLA N/A
- CCIR N/A
- EPS Growth
- PVLA N/A
- CCIR N/A
- EPS
- PVLA N/A
- CCIR 0.12
- Revenue
- PVLA N/A
- CCIR N/A
- Revenue This Year
- PVLA N/A
- CCIR N/A
- Revenue Next Year
- PVLA N/A
- CCIR N/A
- P/E Ratio
- PVLA N/A
- CCIR $84.80
- Revenue Growth
- PVLA N/A
- CCIR N/A
- 52 Week Low
- PVLA $11.17
- CCIR $9.92
- 52 Week High
- PVLA $40.50
- CCIR $13.35
- Technical
- Relative Strength Index (RSI)
- PVLA N/A
- CCIR N/A
- Support Level
- PVLA N/A
- CCIR N/A
- Resistance Level
- PVLA N/A
- CCIR N/A
- Average True Range (ATR)
- PVLA 0.00
- CCIR 0.00
- MACD
- PVLA 0.00
- CCIR 0.00
- Stochastic Oscillator
- PVLA 0.00
- CCIR 0.00
About PVLA Palvella Therapeutics Inc. Common Stock
Palvella Therapeutics Inc is a late clinical-stage biopharmaceutical company committed to serving individuals suffering from serious, rare genetic skin diseases without approved therapies. The Company's lead product candidate, QTORIN 3.9 percent rapamycin anhydrous gel (QTORIN rapamycin), is based on the Company's patented QTORIN platform. QTORIN rapamycin is in clinical development for two rare genetic skin disorders.
About CCIR COHEN CIRCLE ACQUISITION CORP I
Cohen Circle Acquisition Corp I is a blank check company.